{
    "nctId": "NCT04045522",
    "briefTitle": "Study on Bisphosphonates Targeting Triple-negative Breast Cancer",
    "officialTitle": "A Multicenter Prospective Real-world Study on Bisphosphonates Targeting Triple-negative Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Pathologic complete response time",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* developing breast cancer as confirmed by X-ray examination, and cancer tissue was negative for estrogen receptor, progesterone receptor and HER2\n* presence of metastatic axillary lymph nodes\n* standardized adjuvant therapy\n* age over 55 years\n\nExclusion Criteria:\n\n* pregnant or lactating women\n* those allergic to bisphosphonates\n* those who are participating in other trials",
    "sex": "FEMALE",
    "minimumAge": "55 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}